Ultra-early Identification of Fetal Chromosomal Characteristics From Extravillous-trophoblast Cells
Recruiting now
Conditions studied: Pregnant Women
In brief
Demonstrate the efficacy of an ultra-early, non-invasive prenatal diagnostic method adaptable to various genetic indications to detect fetal chromosomal abnormalities.
Key facts
- Study ID
- NCT06523543
- Run by
- University Hospital, Montpellier
- People needed
- 25
- Starts
- 2024-11-19
- Expected to finish
- 2028-09-01
- Last updated by the study team
- 2026-03-13
Who can join
Age: 18 and older. Sex: female. Healthy volunteers: accepted.
You may qualify if…
- Pregnant woman
- Singleton pregnancy
- Pregnancy between 7 and 16 weeks of amenorrhea (WA)
- Woman ≥ 18 years
- Woman who has signed an informed consent
- Woman affiliated to social security or equivalent scheme
- Exclusions Criteria:
- Person under guardianship or curatorship
- Person placed under legal protection
- Person unable to provide the participant with informed consent.
Where it is running
- CHU de Montpellier — Montpellier, France, France (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.